No Data
No Data
ReShape Lifesciences Announces It Will Present Pre-Clinical Data On Its Proprietary Diabetes Neuromodulation Device in Poster Presentation At 12th Annual Minnesota Neuromodulation Symposium May 2, 2025
ReShape Lifesciences Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium
Sector Update: Health Care Stocks Lower in Afternoon Trading
Top Midday Gainers
12 Health Care Stocks Moving In Monday's Intraday Session
ReShape Lifesciences Shares Are Trading Higher After the Company Announced It Received a Notice of Allowance for a Patent From the USPTO.